RGD Reference Report - Phenotyping of congenic dipeptidyl peptidase 4 (DP4) deficient Dark Agouti (DA) rats suggests involvement of DP4 in neuro-, endocrine, and immune functions. - Rat Genome Database

Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

Phenotyping of congenic dipeptidyl peptidase 4 (DP4) deficient Dark Agouti (DA) rats suggests involvement of DP4 in neuro-, endocrine, and immune functions.

Authors: Frerker, Nadine  Raber, Kerstin  Bode, Felix  Skripuletz, Thomas  Nave, Heike  Klemann, Christian  Pabst, Reinhard  Stephan, Michael  Schade, Jutta  Brabant, Georg  Wedekind, Dirk  Jacobs, Roland  Jörns, Anne  Forssmann, Ulf  Straub, Rainer H  Johannes, Sigrid  Hoffmann, Torsten  Wagner, Leona  Demuth, Hans-Ulrich  von Hörsten, Stephan 
Citation: Frerker N, etal., Clin Chem Lab Med. 2009;47(3):275-87. doi: 10.1515/CCLM.2009.064.
RGD ID: 41408336
Pubmed: (View Article at PubMed) PMID:19327106
DOI: Full-text: DOI:10.1515/CCLM.2009.064


BACKGROUND: Treatment of diabetes type 2 using chronic pharmacological inhibition of dipeptidyl peptidase 4 (DP4) still requires an in-depth analysis of models for chronic DP4 deficiency, because adverse reactions induced by some DP4 inhibitors have been described.
METHODS: In the present study, a novel congenic rat model of DP4 deficiency on a "DP4-high" DA rat genetic background was generated (DA.F344-Dpp4(m)/ SvH rats) and comprehensively phenotyped.
RESULTS: Similar to chronic pharmacological inhibition of DP4, DP4 deficient rats exhibited a phenotype involving reduced diet-induced body weight gain and improved glucose tolerance associated with increased levels of glucagon-like peptide-1 (GLP-1) and bound leptin as well as decreased aminotransferases and triglycerides. Additionally, DA.F344-Dpp4(m)/SvH rats showed anxiolytic-like and reduced stress-like responses, a phenomenon presently not targeted by DP4 inhibitors. However, several immune alterations, such as differential leukocyte subset composition at baseline, blunted natural killer cell and T-cell functions, and altered cytokine levels were observed.
CONCLUSIONS: While this animal model confirms a critical role of DP4 in GLP-1-dependent glucose regulation, genetically induced chronic DP4 deficiency apparently also affects stress-regulatory and immuneregulatory systems, indicating that the use of chronic DP4 inhibitors might have the potential to interfere with central nervous system and immune functions in vivo.



Gene Ontology Annotations    

Biological Process

Objects Annotated

Genes (Rattus norvegicus)
Dpp4  (dipeptidylpeptidase 4)
Dpp4DPPIV  (dipeptidylpeptidase 4; DPPIV mutant)

Strains
DA.F344-Dpp4DPPIV/SvH  (NA)


Additional Information